Article

To fully tackle the gang of four, needs-driven R & D is essential. Authors' reply [6].

2006-06-01

Abstract excerpt

We appreciate the comments by our colleagues from the Drugs for Neglected Diseases initiative (DNDi) highlighting the importance of research and development programs for a new generation of control tools (e.g., drugs, diagnostics, vaccines, surveillance instruments) to combat the neglected tropical diseases [1]. Indeed, we have great admiration for the outstanding track record of the DNDi along with its si...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 422125a7-251c-5cef-b0c5-71a58d34949b
DOI: 10.1371/journal.pmed.0030284

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

To fully tackle the gang of four, needs-driven R & D is essential. Authors' reply [6].DOI 10.1371/journal.pmed.0030284Read

Developing an Aggregator Mechanism for Late-Stage Clinical Trials of Neglected Disease Product CandidatesSemantic proximity Read

Ken Warren and the Rockefeller Foundation’s Great Neglected Diseases Network, 1978–1988: The Transformation of Tropical and Global MedicineSemantic proximity Read

The Significant Contribution of Pasteur Institute of Iran to COVID-19 Pandemic Control: A Successful Map over the ObstaclesSemantic proximity Read

DRUG DISCOVERY AND DEVELOPMENT FOR NEGLECTED TROPICAL DISEASESSemantic proximity Read

Development and validation of a framework to improve neglected tropical diseases surveillance and response at the sub-national level in KenyaSemantic proximity Read

Living mapping review of global research funding for infectious diseases with a pandemic potential – Pandemic PACT Grant TrackerSemantic proximity Read

Healthcare Policies to Eliminate Neglected Tropical Diseases (NTDs) in India: A RoadmapSemantic proximity Read

Prioritising pathogens for the management of severe febrile patients to improve clinical care in low- and middle-income countriesSemantic proximity Read

Preparing for Next-Generation Antimalarials in Nigeria: A Pre-Introduction Readiness Assessment with Focus on Infant-Friendly Formulations and Emerging TherapiesSemantic proximity Read

Living mapping review of global research funding for pandemic-prone infectious diseases– Pandemic PACT Grant TrackerSemantic proximity Read

[Measles. 2010 elimination goal missed?].Semantic proximity Read

Real-Life Practice of Kelleni’s Protocol in Treatment and Post Exposure Prophylaxis of SARS CoV-2 Omicron HV.1 and JN.1 SubvariantsSemantic proximity Read